West Pharmaceutical Services Inc

WST•NYSE•HEALTHCARE

$328.20-27.28 (-7.67%)

-0.6% 30D•Market closed•Prev $355.48

+$53.68+19.6%

1 month

-3.6%

price return

Year to date

+18.9%

price return

Recent earnings

3/4

quarters beat

Big funds

8

hold this stock

News tone

Bullish

50 articles, 7 days

Key stats

Jul 27

Market cap: $23.10B
P/E: 42.0x
Forward P/E: 38.2x
Dividend yield: 0.24%
Beta: 1.16
Volume: 1.51M
52-week range: $223.66 - $386.00

Analysts

What do analysts expect?

Current

$328.20

Target

$397.29

+69.09 (+21.1%) possible upside12 months

Fundamentals

Business quality, value, and expectations at a glance.

Fundamentals

Is the business strong?

Richly priced and profitable.

Revenue (TTM): $3.2B
Net income (TTM): $543M
Net margin: 17.0%
P/E: 42.02
Forward P/E: 38.17
Market cap: $23.1B

Valuation

P/S6.94
P/B7.72
Dividend yield0.2%

Quality

Operating margin20.5%
ROE19.1%
ROA11.4%

Growth

Beta1.16

Earnings

Recent earnings versus expectations

Last 8 quarters

QuarterEPS resultNext day

Q2 '26No comparison-7.7%

Q1 '26beat +26.8%-1.1%

Q4 '25beat +11.5%+2.8%

Q3 '25beat +14.6%-3.2%

Q2 '25beat +19.5%Not available

Q1 '25beat +15.1%Not available

Smart money

Filed positions and reported activity tied to this stock.

8 funds hold a position and insiders have been net selling.

Real smart money

Funds holding this stock

8 holders

Combined position$2.8B

FP
Findlay Park Partners LLP
Q1 2026 13F
$154.6M
position
SC
Steadfast Capital Management LP
Q4 2025 13F
$118.3M
position
VG
Viking Global
Q4 2025 13F
$81.2M
position
C
Citadel
Ken Griffin · Q1 2026 13F
$81.1M
position
B
BlackRock
Q1 2026 13F
$1.7B
position

Show all 8 holders

FL
FMR LLC
Q1 2026 13F
$313.2M
position
JC
JPMorgan Chase
Q1 2026 13F
$255.8M
position
GF

Insiders

What insiders are doing

2 trades · 6 mo

Sold$1.1M

Sells (2)

FA
Favorite Annette F
Sr. VP & Chief HR Officer · Cluster · Apr 29
$860K
sold
WC
Winters Chad
VP, Chief Accounting Officer · Cluster · Apr 29
$269K
sold

Checking federal contract awards

Coverage gaps for WSTNo recent market-voice mention

Technicals

Trend, range, and the price levels that matter.

Technicals

Price structure

This stock is under pressure, and looks oversold after a sharp drop.

Trend

Under pressure

25 / 100

RSI 14

30oversold

20D volatility

35%annualized

52-week range

$328.20

$223.66$386.00

20D support

$327.97recent floor

20D resistance

$386.00recent ceiling

Returns

5D -8.4%20D -5.3%60D +12.4%

Price vs moving averages

SMA20 -7.9%SMA50 -2.0%SMA200 +16.1%

Volume pace

1.00xvs prior 20D

News

Recent coverage and its overall tone.

News

What the news says

50 articles · 7 days

Coverage is bullish

36 bullish · 11 neutral · 3 bearish

Tone of tracked coverage

Arrowstreet Capital Limited Partnership Purchases 210,112 Shares of West Pharmaceutical Services, Inc. $WST
BullishJul 26
West Pharmaceutical Services, Inc. $WST Shares Acquired by Bank of Nova Scotia
BullishJul 26
West Pharmaceutical (WST) Signs Decade Long Daikyo Distribution Deal Beyond Japan
Leans bullishJul 26
West Pharmaceutical Services, Inc. Revenue Breakdown – MIL:1WST
NeutralJul 25
West Pharmaceutical Services, Inc. $WST Shares Sold by KBC Group NV
Leans bullishJul 25
MLAB|Mesa Laboratories Inc|Price:97.500|Chg%:-3.450
Leans bullishJul 25
Tenon Medical Inc|Price:0.190|Chg%:-0.007
NeutralJul 25
NTRB|Nutriband Inc|Price:2.980|Chg%:+0.050
Leans bullishJul 25

Q4 '24beat +6.4%Not available

Q3 '24beat +24.2%Not available

Q2 '26No comparison

EPS not reportedNext day -7.7%

Q1 '26beat +26.8%

$2.13 actualNext day -1.1%

Q4 '25beat +11.5%

$2.04 actualNext day +2.8%

Q3 '25beat +14.6%

$1.96 actualNext day -3.2%

Q2 '25beat +19.5%

$1.84 actualNext day not available

Q1 '25beat +15.1%

$1.45 actualNext day not available

Q4 '24beat +6.4%

$1.82 actualNext day not available

Q3 '24beat +24.2%

$1.85 actualNext day not available

Gates Foundation Trust

Q1 2026 13F

$111.4M

position